Author

B. Allard

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Assay:metabolomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1

Frequent Co-Authors

J. Stagg· 2 shared B. H. Nelson· 1 shared B. Pauly· 1 shared C. Baker· 1 shared C. Gaebler· 1 shared D. Allard· 1 shared D. M. Margolis· 1 shared E. H. Ma· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

J. Stagg

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The CD73 immune checkpoint promotes tumor cell metabolic fitness

D. Allard, I. Cousineau, E. H. Ma, B. Allard, Y. Bareche, H. Fleury, J. Stagg

This study identifies CD73 as a metabolic regulator in tumor cells, showing it enhances mitochondrial respiration and aspartate biosynthesis, and that targeting CD73 reduces metabolic fitness and genomic stability.

eLife · Jun 1, 2023Peer-reviewedCancer Biology

Sequence evaluation and comparative analysis of novel assays for intact proviral HIV-1 DNA

C. Gaebler, S. D. Falcinelli, E. Stoffel, J. Read, R. Murtagh, T. Oliveira, V. Ramos, J. C. Lorenzi, J. L. Kirchherr, K. S. James, B. Allard, C. Baker, J. D. Kuruc, M. Caskey, N. Archin, , M. C. Nussenzweig

This study compares two novel assays, IPDA and Q4PCR, for measuring intact HIV proviral DNA in ART-suppressed individuals, finding significant differences in their frequency estimates.

bioRxiv · Oct 7, 2020Microbiology

1-Methylnicotinamide is an immune regulatory metabolite in human ovarian cancer

M. K. Kilgour, S. MacPherson, L. Zacharias, S. Keyes, B. Pauly, B. Allard, J. Smazynski, P. H. Watson, J. Stagg, B. H. Nelson, R. J. DeBerardinis, P. T. Hamilton, J. J. Lum

This study identifies 1-methylnicotinamide (MNA) as an immune regulatory metabolite in high-grade serous ovarian cancer, showing its role in modulating T cell function through non-cell autonomous mechanisms.

bioRxiv · May 5, 2020Immunology